Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors

Journal of Medicinal Chemistry

Volumn 42, Issue 3, 1999, Pages 438-445

  Gharagozloo, Parviz ^a   Lazareno, Sebastian ^a   Popham, Angela ^a   Birdsall, Nigel J M ^b  

^a Med Res Cncl Collaborative Centre   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRUCINE; MUSCARINIC AGENT; N 4 METHYLBIPHENYLSTRYCHNINE IODIDE; N PHENYLETHYLSTRYCHNINE BROMIDE; STRYCHNINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CHOLINERGIC SYSTEM; DRUG INDICATION; DRUG SELECTIVITY; NONHUMAN; RECEPTOR AFFINITY;

ALLOSTERIC REGULATION; ANIMALS; CHO CELLS; CRICETINAE; HUMANS; MUSCARINIC ANTAGONISTS; N-METHYLSCOPOLAMINE; RECEPTORS, MUSCARINIC; STRUCTURE-ACTIVITY RELATIONSHIP; STRYCHNINE;

EID: 0033007440     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970799y     Document Type: Article

References (27)

1. For a review, see: Caulfield, M. P. Muscarinic receptors-characterization, coupling and function. Pharmacol. Ther. 1993, 58, 319-379.
2. Caulfield, M. P.; Birdsall, N. J. M. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 1998, 50, 279-290.
3. Hulme, E. C.; Birdsall, N. J. M.; Buckley, N. J. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 1990, 30, 633-673.
4. Kawakami, Y.; Inoue, A.; Kawai, T.; Wakita, M.; Sugimoto, H.; Hopfinger, A. J. The rationale for E2020 as a potent acetylcholinesterase inhibitor. Bioorg. Med. Chem. 1996, 4, 1429-1446.
5. Wagstaff, A. J.; McTavish, D. Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease. Drugs Aging. 1994, 4, 510-540.
6. Lambrecht, G.; Moser, U.; Grimm, U.; Hermann, U.; Hildebrandt, C.; Waelbroeck, M.; Christophe, J.; Mutschler, E. New functionally selective muscarinic agonists. Life Sci. 1993, 52, 481-486.
7. Ensinger, H. A.; Doods, H. N.; Immel-Sehr, A. R.; Kuhn, F. J.; Lambrecht, G.; Mendia, K. D.; Muller, R. E.; Mutschler, E.; Sagrada, A.; Walther, G.; Hammer, R. WAL 2014 - a muscarinic agonist with preferential neuron-stimulating properties. Life Sci. 1993, 52, 473-480.
8. Freedman, S. B.; Dawson, G. R.; Iversen, L. L.; Baker, R.; Hargreaves, R. J. The design of novel partial muscarinic agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo. Life Sci. 1993, 52, 489-495.
9. Jaen, J.; Barrett, S.; Brann, M.; Callahan, M.; Davis, R.; Doyle, P.; Eubanks, D.; Lauffer, L.; Lipinski, W.; Moreland, D.; Nelson, C.; Raby, C.; Schwarz, R.; Spencer, C.; Tecle, H. In vitro and in vivo evaluation of the subtype-selective agonist PD 151832. Life Sci. 1995, 56, 845-852.
10. Caulfield, M. P. Muscarinic receptor classification. In Muscarinic receptor subtypes in smooth muscle; Eglen, R. M., Ed.; CRC Press: New York, 1997; pp 1-37.
11. Clark, A. L.; Mitchelson, F. The inhibitory effect of gallamine on muscarinic receptors. Br. J. Pharmacol. 1976, 58, 323-331.
12. Stockton, J. M.; Birdsall, N. J. M.; Burgen, A. S.; Hulme, E. C. Modification of the binding properties of muscarinic receptors by gallamine. Mol. Pharmacol. 1983, 23, 551-557.
13. Ehlert, F. J. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium. J. Pharmacol. Exp. Ther. 1988, 247, 596-602.
14. Lee, N. H.; El-Fakahany, E. E. Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem. Pharmacol. 1991, 42, 199-205.
15. Lazareno, S.; Birdsall, N. J. M. Detection, quantitation and verification of allosteric interactions of agents with labelled and unlabelled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol. Pharmacol. 1995, 48, 362-378.
16. Tucek, S.; Musilkova, J.; Nedoma, J.; Proska, J.; Shelkovnikov, S.; Vorlicek, J. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors. Mol. Pharmacol. 1990, 38, 674-680.
17. Proska, J.; Tucek, S. Competition between positive and negative allosteric effectors on muscarinic receptors. Mol. Pharmacol. 1995, 48, 696-702.
18. Jakubik, J.; Bakakova, L.; El-Fakahany, E. E.; Tucek, S. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Mol. Pharmacol. 1997, 52, 172-179.
19. Lazareno, S.; Gharagozloo, P.; Popham, A.; Birdsall, N. J. M. Unpublished work.
20. (a) Birdsall, N. J. M; Fairies, T.; Gharagozloo, P.; Kobayashi, S.; Kuonen, D., Lazareno, S.; Popham, A.; Sugimoto, M. Selective allosteric enhancement of the binding and actions of acetylcho-line at muscarinic receptor subtypes. Life Sci. 1997, 60, 1047-1052.
21. (b) Birdsall, N. J. M.; Farries, T.; Gharagozloo, P.; Kobayashi, S.; Lazareno, S.; Sugimoto, M. Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: functional studies. Mol. Pharmacol., in press.
22. Lazareno, S.; Gharagozloo, P.; Kuonen, D.; Popham, A.; Birdsall, N. J. M. Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies. Mol. Pharmacol. 1998, 53, 573-589.
23. Hiraoka, T.; Birdsall, N. J. M.; Gharagozloo, P.; Lazareno, S.; Strychnine and Brucine derivs., indole derivs. and pentacyclic tetrahydrocarbazoles as allosteric effectors at muscarinic receptors. Brit. UK Pat. Appl. 2292685 A, 1996; Chem. Abstr. 1996, 125, 86966d.
24. Oesterlin, M. Investigations and Reactions with Strychnine Oxide. Chem. Ber. 1943, 76B, 224-229.
25. Tamura, Y.; Minamikawa, J.; Ikeda, M. o-Mesitylenesulphonyl-hydroxylamine and Related Compounds - Powerful Aminating Reagents. Synthesis 1977, 1-17.
26. Tamura, Y. Tertiary amines, Novel Method for 1,1,1-Trisubstituted Hydrazinium Salts. Tetrahedron 1973, 29, 1063-1068.
27. Caws, A. C.; Foster, G. E. The purity of chloroform B.P. J. Pharm. Pharmacol. 1957, 9, 824-832.